Cerebraim

WIPO WIPO 2020

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke Cerebraim wurde als Wortmarke am 08.07.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 28. April 2022

Markenform Wortmarke
Aktenzeichen 1568567
Länder Schweiz China Vereinigte Staaten von Amerika (USA)
Basismarke EU Nr. 018265632, 03. Juli 2020
Anmeldedatum 08. Juli 2020
Ablaufdatum 08. Juli 2030

Markeninhaber

6th Floor, 25 Farringdon Street
London EC4A 4AB
GB

Markenvertreter

Botanic House, 100 Hills Road GB

Waren und Dienstleistungen

09 Computer software and programmes; computer software for scientific and medical analysis; downloadable computer software applications; computer software platforms; data processing apparatus; artificial intelligence software; artificial intelligence software for healthcare; artificial intelligence software for personalised medicines; software that provides medical assessment in real time based on artificial intelligence and using algorithm based machine learning technology; software for monitoring, analysing, controlling and running medical operations; downloadable electronic publications; downloadable teaching, instructional and educational material; electronic databases
42 Software as a service [SaaS]; platforms for artificial intelligence as software as a services [SaaS]; research in the field of artificial intelligence; providing on-line non-downloadable software in the field of biotechnology; software design and development services; computer programming; computer programming; computer systems design and development; research relating to the development of computer programs and software; research, development and testing of software and algorithms for health care services; analysis of scientific data; authentication and testing of pharmaceuticals; scientific, pharmaceutical and medical research and development services; personalised medicine research and development services; research, design, development and testing of new products; pharmaceutical products research, design, development and testing; research, design, development and testing services in the field of biotechnology; information, advisory and consultancy services relating to all the aforesaid; including all of the aforesaid services provided on-line from a computer database and/or intranets and/or Extranets and/or the Internet
44 Healthcare services; health risk assessments; pharmaceutical services; advisory services relating to pharmaceuticals; analysis of healthcare and medical data; medical testing for diagnostic or treatment purposes; providing medical testing and reporting services for the susceptibility, risk, diagnosis, prognosis, treatment and management of diseases; real time support medical services for medical decisions using algorithm-based machine learning; information, advisory and consultancy services relating to all the aforesaid; including all of the aforesaid services provided on-line from a computer database and/or intranets and/or Extranets and/or the Internet
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
25. April 2022 2022/17 Gaz US RAW: Rule 18ter(2)(ii) GP following a provisional refusal
25. November 2021 2021/47 Gaz CH Ablehnung
13. Mai 2021 2021/19 Gaz CN Ablehnung
01. Februar 2021 2021/5 Gaz US Ablehnung
08. Juli 2020 2020/52 Gaz EM Eintragung

ID: 141568567